In vivo and enzymatic conversion of toyocamycin to sangivamycin by Streptomyces rimosus.
D000900:Anti-Bacterial Agents / Q000378:metabolism*; D000963:Antimetabolites / Q000494:pharmacology; D002413:Cations, Divalent; D002474:Cell-Free System; D002852:Chromatography, Ion Exchange; D002854:Chromatography, Paper; D006863:Hydrogen-Ion Concentration; D006867:Hydrolases / Q000037:antagonists & inhibitors / Q000302:isolation & purification / Q000378:metabolism; D006882:Hydroxyapatites; D007700:Kinetics; D009570:Nitriles / Q000494:pharmacology; D011684:Purine Nucleosides / Q000096:biosynthesis / Q000378:metabolism*; D013045:Species Specificity; D013056:Spectrophotometry, Ultraviolet; D013302:Streptomyces / Q000378:metabolism*; D014316:Tritium
D000900:Anti-Bacterial Agents; D000963:Antimetabolites; D002413:Cations, Divalent; D006882:Hydroxyapatites; D009570:Nitriles; D011684:Purine Nucleosides; D014316:Tritium; D006867:Hydrolases